Literature DB >> 30642920

The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.

Xianchi Dong1,2, Nina C Leksa3, Ekta Seth Chhabra3, Joseph W Arndt4, Qi Lu3, Kevin E Knockenhauer3, Robert T Peters3, Timothy A Springer1,2.   

Abstract

D assemblies make up half of the von Willebrand factor (VWF), yet are of unknown structure. D1 and D2 in the prodomain and D'D3 in mature VWF at Golgi pH form helical VWF tubules in Weibel Palade bodies and template dimerization of D3 through disulfides to form ultralong VWF concatemers. D'D3 forms the binding site for factor VIII. The crystal structure of monomeric D'D3 with cysteine residues required for dimerization mutated to alanine was determined at an endoplasmic reticulum (ER)-like pH. The smaller C8-3, TIL3 (trypsin inhibitor-like 3), and E3 modules pack through specific interfaces as they wind around the larger, N-terminal, Ca2+-binding von Willebrand D domain (VWD) 3 module to form a wedge shape. D' with its TIL' and E' modules projects away from D3. The 2 mutated cysteines implicated in D3 dimerization are buried, providing a mechanism for protecting them against premature disulfide linkage in the ER, where intrachain disulfide linkages are formed. D3 dimerization requires co-association with D1 and D2, Ca2+, and Golgi-like acidic pH. Associated structural rearrangements in the C8-3 and TIL3 modules are required to expose cysteine residues for disulfide linkage. Our structure provides insight into many von Willebrand disease mutations, including those that diminish factor VIII binding, which suggest that factor VIII binds not only to the N-terminal TIL' domain of D' distal from D3 but also extends across 1 side of D3. The organizing principle for the D3 assembly has implications for other D assemblies and the construction of higher-order, disulfide-linked assemblies in the Golgi in both VWF and mucins.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30642920      PMCID: PMC6450429          DOI: 10.1182/blood-2018-10-876300

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene.

Authors:  L Hilbert; R D'Oiron; E Fressinaud; D Meyer; C Mazurier
Journal:  J Thromb Haemost       Date:  2004-12       Impact factor: 5.824

Review 3.  Advances and innovations in haemophilia treatment.

Authors:  Rob Peters; Tim Harris
Journal:  Nat Rev Drug Discov       Date:  2018-06-08       Impact factor: 84.694

4.  Structural organization of Weibel-Palade bodies revealed by cryo-EM of vitrified endothelial cells.

Authors:  John A Berriman; Sam Li; Lindsay J Hewlett; Sebastian Wasilewski; Fedir N Kiskin; Tom Carter; Matthew J Hannah; Peter B Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-29       Impact factor: 11.205

5.  Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.

Authors:  Andrew Yee; Austin N Oleskie; Anne M Dosey; Colin A Kretz; Robert D Gildersleeve; Somnath Dutta; Min Su; David Ginsburg; Georgios Skiniotis
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

Review 6.  The international society on thrombosis and haematosis von Willebrand disease database: an update.

Authors:  Daniel J Hampshire; Anne C Goodeve
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

7.  A pH-regulated dimeric bouquet in the structure of von Willebrand factor.

Authors:  Yan-Feng Zhou; Edward T Eng; Noritaka Nishida; Chafen Lu; Thomas Walz; Timothy A Springer
Journal:  EMBO J       Date:  2011-08-19       Impact factor: 11.598

8.  Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity.

Authors:  Lysiane Hilbert; Sylvie Jorieux; Valérie Proulle; Rémi Favier; Jenny Goudemand; Armelle Parquet; Dominique Meyer; Edith Fressinaud; Claudine Mazurier
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

9.  A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization.

Authors:  S Jorieux; C Gaucher; J Goudemand; C Mazurier
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

10.  Solution structure of the major factor VIII binding region on von Willebrand factor.

Authors:  Nuha Shiltagh; John Kirkpatrick; Lisa D Cabrita; Tom A J McKinnon; Konstantinos Thalassinos; Edward G D Tuddenham; D Flemming Hansen
Journal:  Blood       Date:  2014-04-03       Impact factor: 22.113

View more
  24 in total

1.  von Willebrand factor binding to myosin assists in coagulation.

Authors:  Veronica H Flood; Tricia L Slobodianuk; Daniel Keesler; Hannah K Lohmeier; Scot Fahs; Liyun Zhang; Pippa Simpson; Robert R Montgomery
Journal:  Blood Adv       Date:  2020-01-14

2.  Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease.

Authors:  Muhammad Asif Naveed; Aiysha Abid; Nadir Ali; Yaqoob Hassan; Ali Amar; Aymen Javed; Khansa Qamar; Ghulam Mustafa; Ali Raza; Umera Saleem; Shabbir Hussain; Madiha Shakoor; Shagufta Khaliq; Shahida Mohsin
Journal:  Genes (Basel)       Date:  2022-05-28       Impact factor: 4.141

3.  Disulfide exchange in multimerization of von Willebrand factor and gel-forming mucins.

Authors:  Xianchi Dong; Timothy A Springer
Journal:  Blood       Date:  2021-03-04       Impact factor: 22.113

4.  Helical self-assembly of a mucin segment suggests an evolutionary origin for von Willebrand factor tubules.

Authors:  Gabriel Javitt; Deborah Fass
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-04       Impact factor: 12.779

5.  Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor.

Authors:  Lisbeth Dagil; Kathrin S Troelsen; Gert Bolt; Lars Thim; Bo Wu; Xin Zhao; Edward G D Tuddenham; Thomas E Nielsen; David A Tanner; Johan H Faber; Jens Breinholt; Jakob E Rasmussen; D Flemming Hansen
Journal:  Biophys J       Date:  2019-07-11       Impact factor: 4.033

6.  The C-terminal dimerization domain of the respiratory mucin MUC5B functions in mucin stability and intracellular packaging before secretion.

Authors:  Caroline Ridley; Michael P Lockhart-Cairns; Richard F Collins; Thomas A Jowitt; Durai B Subramani; Mehmet Kesimer; Clair Baldock; David J Thornton
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

7.  Calcium-activated chloride channel regulator 1 (CLCA1) forms non-covalent oligomers in colonic mucus and has mucin 2-processing properties.

Authors:  Elisabeth E L Nyström; Liisa Arike; Erik Ehrencrona; Gunnar C Hansson; Malin E V Johansson
Journal:  J Biol Chem       Date:  2019-09-29       Impact factor: 5.157

8.  Intestinal Gel-Forming Mucins Polymerize by Disulfide-Mediated Dimerization of D3 Domains.

Authors:  Gabriel Javitt; María Luisa Gómez Calvo; Lis Albert; Nava Reznik; Tal Ilani; Ron Diskin; Deborah Fass
Journal:  J Mol Biol       Date:  2019-07-13       Impact factor: 5.469

9.  Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor.

Authors:  Wenpeng Cao; Wenjing Cao; Wei Zhang; X Long Zheng; X Frank Zhang
Journal:  J Thromb Haemost       Date:  2020-07-23       Impact factor: 5.824

10.  Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy.

Authors:  James R Fuller; Kevin E Knockenhauer; Nina C Leksa; Robert T Peters; Joseph D Batchelor
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.